Work sharing

CIRS RD Briefing 101 – New drug approvals by six major authorities 2015-2024

This R&D Briefing presents the results from the Centre for Innovation in Regulatory Science (CIRS) annual analysis of new active substance (NAS) approvals by six major regulatory agencies: the [...]

CIRS RD Briefing 97 – Access Consortium and Project Orbis Approvals Across Eight Regulators

This R&D Briefing builds upon the Centre for Innovation in Regulatory Science (CIRS)'s long-standing efforts to examine trends and practices in regulatory approvals. For over 20 years, CIRS has [...]

Go to Top